MEDIZINISCHE RADIOGRAPHIE MIT SCHNELLEN NEUTRONEN = RADIOGRAPHIE MEDICALE AVEC NEUTRONS RAPIDESDUEHMKE E.1980; FORTSCHR. GEB. ROENTGENSTRAHL. NUKLEARMED.; DEU; DA. 1980; VOL. 132; NO 6; PP. 720-728; ABS. ENG; BIBL. 10 REF.Article

ERGEBNISSE DER STRAHLENBEHANDLUNG VON MALIGNEN HYPOPHARYNXTUMOREN - EINE RETROSPEKTIVE ANSWERTUNG VON 50 VERLAEUFEN = RESULTATS DU TRAITEMENT RADIOTHERAPIQUE DE TUMEURS MALIGNES DE L'HYPOPHARYNX. EVALUATION RETROSPECTIVE DE 50 CASDUEHMKE E; CALIEBE W.1981; STRAHLENTHERAPIE; ISSN 0039-2073; DEU; DA. 1981; VOL. 157; NO 5; PP. 297-300; ABS. ENG/FRE; BIBL. 6 REF.Article

THERAPIE DER MALIGNEN LYMPHOME DES OROPHARYNX = TRAITEMENT DES LYMPHOMES MALINS DE L'OROPHARYNXDUEHMKE E; SCHWARZE EW.1981; HNO, HALS-NASEN-OHRENHEILKD.; ISSN 0017-6192; DEU; DA. 1981; VOL. 29; NO 9; PP. 302-307; ABS. ENG; BIBL. 9 REF.Article

BEITRAG ZUM JET-PHAENOMEN IN DER HARNBLASE. = CONTRIBUTION SUR PHENOMENE DE JET DANS LA VESSIEDUEHMKE E; GABRIEL JUERGENS P; KALKHOF HG et al.1978; FORTSCHR. GEB. ROENTGENSTRAHL. NUKLEARMED.; DTSCH.; DA. 1978; VOL. 128; NO 3; PP. 286-290; ABS. ANGL.; BIBL. 11 REF.Article

GERMINAL CENTER CELL LYMPHOMAS: PROGNOSTIC SIGNIFICANCE OF THEIR HISTOPATHOLOGICAL DIFFERENTIATIONKOENIG E; BARTELS H; BREMER K et al.1981; BLUT; ISSN 0006-5242; DEU; DA. 1981; VOL. 43; NO 3; PP. 193-200; BIBL. 22 REF.Article

A skin MR-marker for radiation treatment planningMATTHAEI, D; SEHLEN, S; KOCH, H et al.Strahlentherapie und Onkologie. 1992, Vol 168, Num 4, pp 237-239, issn 0179-7158Article

Radiotherapeutische Qualitätssicherung in der BMFT-Studie Morbus Hodgkin (HD4) = Radiotherapeutic quality control in the BMFT study Morbus Hodgkin (HD4)ROTH, S. L; DUÊHMKE, E; KIRSCHNER, H et al.Strahlentherapie und Onkologie. 1990, Vol 166, Num 9, pp 584-587, issn 0179-7158, 4 p.Article

Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trialSIEBER, M; TESCH, H; ROLLER, S et al.Annals of oncology. 2004, Vol 15, Num 2, pp 276-282, issn 0923-7534, 7 p.Article

BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma : Interim report from a trial of the German Hodgkin's Lymphoma Study GroupDIEHL, V; FRANKLIN, J; ENGERT, A et al.Journal of clinical oncology. 1998, Vol 16, Num 12, pp 3810-3821, issn 0732-183XArticle